Serologic Response of 2 Versus 3 Doses and Intradermal Versus Intramuscular Administration of a Licensed Rabies Vaccine for Preexposure Prophylaxis

被引:9
|
作者
Endy, Timothy P. [1 ]
Keiser, Paul B. [2 ]
Wang, Dongliang [3 ]
Jarman, Richard G. [2 ]
Cibula, Don [3 ]
Fang, Hengsheng [1 ]
Ware, Lisa [4 ]
Abbott, Mark [4 ]
Thomas, Stephen J. [4 ]
Polhemus, Mark E. [4 ]
机构
[1] SUNY Upstate Med Univ, Dept Microbiol & Immunol, 766 Irving Ave,Room 2204, Syracuse, NY 13210 USA
[2] Walter Reed Army Inst Res, Silver Spring, MD USA
[3] SUNY Upstate Med Univ, Dept Publ Hlth, Syracuse, NY 13210 USA
[4] SUNY Upstate Med Univ, Inst Global Heath & Translat Sci, Syracuse, NY 13210 USA
来源
JOURNAL OF INFECTIOUS DISEASES | 2020年 / 221卷 / 09期
关键词
rabies; vaccine; intradermal; intramuscular; immunogenicity;
D O I
10.1093/infdis/jiz645
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The World Health Organization recommends intradermal (ID) administration of rabies vaccine for preexposure prophylaxis. Methods. In a randomized trial in adults assigned to 1 of 6 treatment groups (ID vs intramuscular [IM], 2 vs 3 doses, and controls), rabies neutralizing antibody titers were measured to 1 year postvaccination. Results. ID vaccination produced acceptable antibody levels in all subjects (2- and 3-dose groups). At day 365, acceptable levels were 40% for IM and 50% for ID 2-dose schedule, and 70% for IM and 60% for ID 3-dose schedule. Conclusions. ID rabies vaccination induces acceptable antibody titers at a fraction of the dose.
引用
收藏
页码:1494 / 1498
页数:5
相关论文
共 23 条
  • [1] A Cross Sectional Study- Intradermal Versus Intramuscular Anti Rabies Prophylaxis
    Sumit, Aggarwal
    Rajesh, Chaugule
    Santosh, Haralkar
    Nandkeshav, Aswar R.
    Kanchan, Khandare
    Anjali, Kumavat P.
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2015, 3 (01): : 31 - 34
  • [2] Persistence of antibodies in children after intradermal or intramuscular administration of preexposure Primary and booster immunizations with purified Vero cell rabies vaccine
    Sabchareon, A
    Chantavanich, P
    Pasuralertsakul, S
    Pojjaroen-Anant, C
    Prarinyanupharb, V
    Attanath, P
    Singhasivanon, V
    Buppodom, W
    Lang, J
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (11) : 1001 - 1007
  • [3] Cost-effectiveness analysis of intradermal versus classical intramuscular COVID-19 vaccine administration
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2022, 17 (01)
  • [4] INTRAMUSCULAR VERSUS INTRADERMAL ADMINISTRATION OF A RECOMBINANT HEPATITIS-B VACCINE - A COMPARISON OF RESPONSE RATES AND ANALYSIS OF FACTORS INFLUENCING THE ANTIBODY-RESPONSE
    STRUVE, J
    ARONSSON, B
    FRENNING, B
    GRANATH, F
    VONSYDOW, M
    WEILAND, O
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1992, 24 (04) : 423 - 429
  • [5] Noninferiority Study of Purified Vero Rabies Vaccine-Serum Free in 3-dose and 2-dose Preexposure Prophylaxis Regimens in Comparison With Licensed Rabies Vaccines
    Chokephaibulkit, Kulkanya
    Huoi, Catherine
    Tantawichien, Terapong
    Mootsikapun, Piroon
    Kosalaraksa, Pope
    Kiertiburanakul, Sasisopin
    Ratanasuwan, Winai
    Vangelisti, Manuel
    Laot, Thelma
    Huang, Youjun
    Petit, Celine
    Pineda-Pena, Andrea-Clemencia
    Frago, Carina
    CLINICAL INFECTIOUS DISEASES, 2025,
  • [6] EVALUATION OF JAPANESE B-ENCEPHALITIS VACCINE .2. SEROLOGIC RESPONSE FOLLOWING SUBCUTANEOUS AND INTRADERMAL ADMINISTRATION
    MATUMOTO, M
    KITAOKA, M
    BURNS, KF
    AMERICAN JOURNAL OF HYGIENE, 1956, 63 (03): : 228 - 229
  • [7] Low-dose intradermal versus intramuscular administration of recombinant hepatitis B vaccine:: a comparison of immunogenicity in infants and preschool children
    Egemen, A
    Aksit, S
    Kurugöl, Z
    Erensoy, S
    Bilgiç, A
    Akilli, M
    VACCINE, 1998, 16 (16) : 1511 - 1515
  • [8] Intramuscular versus intradermal. administration of anti-hepatitis B vaccine in non-cirrhotic hepatitis C patients
    Arbizu, EA
    Marugán, RB
    Grijalba, JY
    Serrano, PL
    Grande, LG
    Terrón, SD
    VACCINE, 2003, 21 (21-22) : 2747 - 2750
  • [9] A RIFT-VALLEY FEVER VACCINE TRIAL .2. SEROLOGICAL RESPONSE TO BOOSTER DOSES WITH A COMPARISON OF INTRADERMAL VERSUS SUBCUTANEOUS INJECTION
    KARK, JD
    AYNOR, Y
    PETERS, CJ
    VACCINE, 1985, 3 (02) : 117 - 122
  • [10] Comparative immunogenicity analysis of intradermal versus intramuscular administration of SARS-CoV-2 RBD epitope peptidebased immunogen In vivo
    Yadav, Naveen
    Vishwakarma, Preeti
    Khatri, Ritika
    Siddqui, Gazala
    Awasthi, Amit
    Ahmed, Shubbir
    Samal, Sweety
    MICROBES AND INFECTION, 2021, 23 (4-5)